Table 1.
Antibiogram of Staphylococcus aureus strains used in this study.
| Antibiotic | ATCC 29213 (MIC) | MRSA 1 (MIC) | MRSA 2 (MIC) |
|---|---|---|---|
| Cefoxitin detection | NEG | POS | POS |
| Benzylpenicillin | R (≥ 0.5) | R (≥ 0.5) | R (≥ 0.5) |
| Oxacillin | S (≤ 0.25) | R (≥ 4) | R (≥ 4) |
| Ceftaroline | S (0.25) | R (0.5) | S (0.25) |
| Gentamycin | S (≤ 0.5) | S (≤ 0.5) | S (≤ 0.5) |
| Tobramycin | S (≤ 1) | R (≥ 16) | S (≤ 1) |
| Levofloxacin | I (0.25) | R (≥ 8) | R (≥ 8) |
| Inducible resistance to clindamycin | NEG | NEG | NEG |
| Erythromycin | S (1) | R (≥ 8) | R (≥ 8) |
| Clindamycin | S (0.25) | R (≥ 8) | S (0.25) |
| Linezolid | S (2) | S (1) | S (2) |
| Daptomycin | S (0.25) | S (0.25) | S (0.25) |
| Teicoplanin | S (≤ 0.5) | S (≤ 0.5) | S (≤ 0.5) |
| Vancomycin | S (1) | S (1) | S (≤ 0.5) |
| Tigecycline | S (≤ 0.12) | S (≤ 0.12) | S (≤ 0.12) |
| Fosfomycin | S (≤ 8) | S (≤ 8) | S (≤ 8) |
| Mupirocin | S (≤ 1) | S (≤ 1) | R (≥ 512) |
| Rifampicin | S (≤ 0.03) | S (≤ 0.03) | S (≤ 0.03) |
| Trimethoprim/Sulfamethoxazole | S (≤ 10) | S (≤ 10) | S (≤ 10) |
MIC, Minimum Inhibitory Concentration (mg/L); S, susceptible; I, intermediate; R, resistant.